Results 201 to 210 of about 22,229,619 (357)
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Generative model for the first cell fate bifurcation in mammalian development. [PDF]
Avdeeva M +4 more
europepmc +1 more source
Correct-by-Construction Vision-based Pose Estimation using Geometric Generative Models
Ulices Santa Cruz +2 more
openalex +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Scalable, trustworthy generative model for virtual multi-staining from H&E whole slide images. [PDF]
Ounissi M +5 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Predictive framework for cervical cancer brachytherapy fractionation mode integrating generative model and dynamic feature aggregation GNNs. [PDF]
Liu X +6 more
europepmc +1 more source
TransitGPT: A Generative AI-based framework for interacting with GTFS data using Large Language Models [PDF]
Saipraneeth Devunuri, Lewis Lehe
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source

